Maravai LifeSciences Acquires MyChem

BioMatrix Infusion Pharmacy Acquires MyLyfe Health

March 3, 2025

Healthcare Services

BioMatrix Infusion Pharmacy, a nationwide specialty infusion pharmacy based in Plantation, Florida, has acquired MyLyfe Health, a New England–based specialty pharmacy and home infusion services provider. The acquisition expands BioMatrix's geographic footprint into New England and enhances its ambulatory and home infusion capabilities to better serve patients with chronic, lifelong conditions.

Maravai LifeSciences to Acquire Officinae Bio's DNA and RNA Business

November 7, 2024

Healthcare Services

Maravai LifeSciences, Inc. signed an agreement to acquire the DNA and RNA business of Officinae Bio. The acquisition is intended to expand Maravai and its TriLink BioTechnologies nucleic acid production capabilities, particularly for AI-enabled nucleic acid sequence design and rapid mRNA candidate prototyping.

Millstone Medical Outsourcing Acquires MycoScience

November 14, 2022

Healthcare Services

Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, has completed the acquisition of MycoScience, a Willington, Connecticut-based provider of medical device and pharmaceutical laboratory and environmental testing services. The acquisition adds advanced laboratory and regulatory testing capabilities to Millstone's post-manufacturing and aftermarket services, enabling more in-house testing, faster time to market, and expanded end-to-end offerings.

Thompson Street Capital Partners Acquires Vector Laboratories (Maravai Protein Detection Business)

September 7, 2021

Biotechnology

Thompson Street Capital Partners (TSCP), a St. Louis-based private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai (NASDAQ: MRVI). Vector Laboratories is a manufacturer of labeling and visual detection reagents used in tissue-based protein detection for academic and corporate research; TSCP said the deal expands its life sciences capabilities and positions Vector for organic and strategic growth.

Verdesian Life Sciences Acquires Cytozyme Laboratories

April 27, 2021

Agriculture

Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.

X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services

January 26, 2021

Biotechnology

X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.